121 related articles for article (PubMed ID: 12503096)
1. What do ratings of cancer-specific distress mean among women at high risk of breast and ovarian cancer?
Coyne JC; Kruus L; Racioppo M; Calzone KA; Armstrong K
Am J Med Genet A; 2003 Jan; 116A(3):222-8. PubMed ID: 12503096
[TBL] [Abstract][Full Text] [Related]
2. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling.
Høberg-Vetti H; Eide GE; Siglen E; Listøl W; Haavind MT; Hoogerbrugge N; Bjorvatn C
Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464
[TBL] [Abstract][Full Text] [Related]
3. Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast/ovarian cancer.
Reichelt JG; Møller P; Heimdal K; Dahl AA
Fam Cancer; 2008; 7(3):245-54. PubMed ID: 18219587
[TBL] [Abstract][Full Text] [Related]
4. Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing.
Lodder L; Frets PG; Trijsburg RW; Klijn JG; Seynaeve C; Tilanus MM; Bartels CC; Meijers-Heijboer EJ; Verhoog LC; Niermeijer MF
Am J Med Genet A; 2003 Jun; 119A(3):266-72. PubMed ID: 12784290
[TBL] [Abstract][Full Text] [Related]
5. Family environments of women seeking BRCA1/BRCA2 genetic mutation testing: an exploratory analysis.
Keenan LA; Lesniak KT; Guarnaccia CA; Althaus B; Ethington G; Blum JL
J Genet Couns; 2004 Apr; 13(2):157-76. PubMed ID: 15604630
[TBL] [Abstract][Full Text] [Related]
6. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
[TBL] [Abstract][Full Text] [Related]
7. Women's satisfaction with genetic counseling for hereditary breast-ovarian cancer: psychological aspects.
Tercyak KP; Demarco TA; Mars BD; Peshkin BN
Am J Med Genet A; 2004 Nov; 131(1):36-41. PubMed ID: 15389697
[TBL] [Abstract][Full Text] [Related]
8. Cancer-specific worry interference in women attending a breast and ovarian cancer risk evaluation program: impact on emotional distress and health functioning.
Trask PC; Paterson AG; Wang C; Hayasaka S; Milliron KJ; Blumberg LR; Gonzalez R; Murray S; Merajver SD
Psychooncology; 2001; 10(5):349-60. PubMed ID: 11536413
[TBL] [Abstract][Full Text] [Related]
9. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
[TBL] [Abstract][Full Text] [Related]
10. Psychological impact of receiving a BRCA1/BRCA2 test result.
Lodder L; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Duivenvoorden HJ; Tibben A; Wagner A; van der Meer CA; van den Ouweland AM; Niermeijer MF
Am J Med Genet; 2001 Jan; 98(1):15-24. PubMed ID: 11426450
[TBL] [Abstract][Full Text] [Related]
11. Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: the contributions of personality and appraisal.
Audrain J; Schwartz MD; Lerman C; Hughes C; Peshkin BN; Biesecker B
Ann Behav Med; 1997; 19(4):370-7. PubMed ID: 9706364
[TBL] [Abstract][Full Text] [Related]
12. Psychological adjustment among male partners in response to women's breast/ovarian cancer risk: a theoretical review of the literature.
Sherman KA; Kasparian NA; Mireskandari S
Psychooncology; 2010 Jan; 19(1):1-11. PubMed ID: 19472298
[TBL] [Abstract][Full Text] [Related]
13. Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs.
Dorval M; Patenaude AF; Schneider KA; Kieffer SA; DiGianni L; Kalkbrenner KJ; Bromberg JI; Basili LA; Calzone K; Stopfer J; Weber BL; Garber JE
J Clin Oncol; 2000 May; 18(10):2135-42. PubMed ID: 10811679
[TBL] [Abstract][Full Text] [Related]
14. BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships.
McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
Am J Med Genet A; 2005 Mar; 133A(2):165-9. PubMed ID: 15633195
[TBL] [Abstract][Full Text] [Related]
15. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.
Bonadona V; Saltel P; Desseigne F; Mignotte H; Saurin JC; Wang Q; Sinilnikova O; Giraud S; Freyer G; Plauchu H; Puisieux A; Lasset C
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):97-104. PubMed ID: 11815406
[TBL] [Abstract][Full Text] [Related]
16. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
17. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.
Claes E; Evers-Kiebooms G; Boogaerts A; Decruyenaere M; Denayer L; Legius E
Am J Med Genet A; 2003 Jan; 116A(1):11-9. PubMed ID: 12476445
[TBL] [Abstract][Full Text] [Related]
18. Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review.
Pasacreta JV
Cancer Invest; 2003; 21(4):588-623. PubMed ID: 14533449
[TBL] [Abstract][Full Text] [Related]
19. Benefit finding in response to BRCA1/2 testing.
Low CA; Bower JE; Kwan L; Seldon J
Ann Behav Med; 2008 Feb; 35(1):61-9. PubMed ID: 18347905
[TBL] [Abstract][Full Text] [Related]
20. Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations.
Geirdal AØ; Reichelt JG; Dahl AA; Heimdal K; Maehle L; Stormorken A; Møller P
Fam Cancer; 2005; 4(2):121-6. PubMed ID: 15951962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
